Calcineurin Inhibitors, but not Rapamycin, Reduce Percentages of CD4+CD25+FOXP3+ Regulatory T Cells in Renal Transplant Recipients-Reference-Cited by-同舟云学术

Calcineurin Inhibitors, but not Rapamycin, Reduce Percentages of CD4+CD25+FOXP3+ Regulatory T Cells in Renal Transplant Recipients

Published:2006-08-27 Issue:4 Volume:82 Page:550-557
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Segundo David San,Ruiz Juan Carlos,Izquierdo María,Fernández-Fresnedo Gema,Gómez-Alamillo Carlos,Merino Ramón,Benito María Jesús,Cacho Eva,Rodrigo Emilio,Palomar Rosa,López-Hoyos Marcos,Arias Manuel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference40 articles.

1. Strategies to improve long-term outcome after renal transplantation.;Pascual;N Engl J Med,2002

2. Evolution of endpoints for renal transplant outcome.;Hariharan;Am J Transplant,2003

3. Immunosuppression minimization: current and future trends in transplant immunosuppression.;Vincenti;J Am Soc Nephrol,2003

4. Cellular and genetic mechanisms of self tolerance and autoimmunity.;Goodnow;Nature,2005

5. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.;Sakaguchi;Nat Immunol,2005

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Posttransplant inflammatory bowel disease after successful solid organ transplantation: Not out of the woods yet;Journal of Pediatric Gastroenterology and Nutrition;2024-08-09

2. Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma;Nature Communications;2024-04-30

3. Everolimus and mycophenolate mofetil effectively prevent GvHD in children with severe acute kidney injury undergoing allogeneic HSCT;2024-03-16

4. Tregs in transplantation tolerance: role and therapeutic potential;Frontiers in Transplantation;2023-08-30

5. Regulatory T Cell Biomarkers Identify Patients at Risk of Developing Acute Cellular Rejection in the First Year Following Heart Transplantation;Transplantation;2023-07-20